MediWound Ltd. (MDWD)
Total Valuation
MediWound has a market cap or net worth of $57.66 million. The enterprise value is $42.07 million.
| Market Cap | 57.66M |
| Enterprise Value | 42.07M |
Important Dates
The latest earnings date was Tuesday, May 17, 2022, before market open.
| Last Earnings Date | May 17, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
MediWound has 33.14 million shares outstanding. The number of shares has increased by 5.49% in one year.
| Shares Outstanding | 33.14M |
| Shares Change (YoY) | +5.49% |
| Shares Change (QoQ) | +5.45% |
| Owned by Insiders (%) | 40.40% |
| Owned by Institutions (%) | 8.55% |
| Float | 17.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| PB Ratio | 29.65 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.95 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -59.90% |
| Return on Capital (ROIC) | -493,080.00% |
| Revenue Per Employee | $289,909 |
| Profits Per Employee | -$185,571 |
| Employee Count | 77 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 8.56 |
Taxes
In the past 12 months, MediWound has paid $31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.05% in the last 52 weeks. The beta is 1.40, so MediWound's price volatility has been higher than the market average.
| Beta (1Y) | 1.40 |
| 52-Week Price Change | -56.05% |
| 50-Day Moving Average | 2.01 |
| 200-Day Moving Average | 2.32 |
| Average Volume (30 Days) | 117,422 |
Short Selling Information
The latest short interest is 42,404, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 42,404 |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.64 |
Income Statement
In the last 12 months, MediWound had revenue of $22.32 million and -14.29 million in losses. Earnings per share was -$0.52.
| Revenue | 22.32M |
| Gross Profit | 7.82M |
| Operating Income | -12.58M |
| Pretax Income | -14.26M |
| Net Income | -14.29M |
| EBITDA | -11.08M |
| EBIT | -12.33M |
| Earnings Per Share (EPS) | -$0.52 |
Balance Sheet
The company has $16.84 million in cash and $1.24 million in debt, giving a net cash position of $15.60 million or $0.47 per share.
| Cash & Cash Equivalents | 16.84M |
| Total Debt | 1.24M |
| Net Cash | 15.60M |
| Net Cash Per Share | $0.47 |
| Book Value | 1.95M |
| Book Value Per Share | 0.06 |
| Working Capital | 10.71M |
Cash Flow
In the last 12 months, operating cash flow was -$10.10 million and capital expenditures -$431,000, giving a free cash flow of -$10.53 million.
| Operating Cash Flow | -10.10M |
| Capital Expenditures | -431,000 |
| Free Cash Flow | -10.53M |
| FCF Per Share | n/a |
Margins
Gross margin is 35.01%, with operating and profit margins of -56.37% and -64.01%.
| Gross Margin | 35.01% |
| Operating Margin | -56.37% |
| Pretax Margin | -63.87% |
| Profit Margin | -64.01% |
| EBITDA Margin | -49.62% |
| EBIT Margin | -55.22% |
| FCF Margin | -47.19% |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -24.78% |
| FCF Yield | -18.27% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
The average price target for MediWound is $6.38, which is 266.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.38 |
| Price Target Difference | 266.67% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |